Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.

scientific article published on 26 June 2013

Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BMC.2013.06.040
P698PubMed publication ID23867390
P5875ResearchGate publication ID250919157

P50authorRosaria AcquavivaQ46235596
Ignazio BarbagalloQ47757242
Valeria SorrentiQ48139552
Claudia Di GiacomoQ48139573
Daniele TibulloQ61116197
Valeria PittalàQ79207229
Loredana SalernoQ87561855
P2093author name stringGiuseppe Romeo
Maria A Siracusa
Maria N Modica
P433issue17
P407language of work or nameEnglishQ1860
P304page(s)5145-5153
P577publication date2013-06-26
P1433published inBioorganic & Medicinal ChemistryQ2904200
P1476titleEvaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties
P478volume21

Reverse relations

cites work (P2860)
Q35048909Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Q42374355Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors
Q42459505Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia.
Q46323417Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole
Q38790184Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells
Q64249373Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products
Q38590745HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy
Q38679172Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors.
Q89287854Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib
Q58704216Heme Oxygenase-1 Inhibitors Induce Cell Cycle Arrest and Suppress Tumor Growth in Thyroid Cancer Cells
Q39956732Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells
Q38426058Heme oxygenase-1: emerging target of cancer therapy
Q49327582Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
Q52564046Identification of potentially potent Heme Oxygenase-1 inhibitors through 3D-QSAR coupled to scaffold hopping analysis.
Q90309042New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
Q89706191Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation
Q60503345Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation
Q38758576Synthesis and Anti-Proliferative Activity of Sulfanyltriazolylnaphthalenols and Sulfanyltriazolylnaphthalene-1,4-diones.
Q28077113The non-canonical functions of the heme oxygenases

Search more.